AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

This on-demand webinar explores the changing treatment paradigm for migraine in light of precision medicine and the development of CGRP monoclonal antibodies, and explores how we can develop a new holistic,...
This module explores how to identify risk factors and make a diagnosis of MCI, and outlines the effective development of treatment plans for MCI in primary care.
Part 1 of this 2-hour module contains information about SUDEP (sudden unexpected death in epilepsy) and strategies for discussing the risks of SUDEP with patients and their families

This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.

This program aims to support identification, evaluation and treatment of patients at high risk of osteoporotic fracture.

This module looks at the symptoms and management of common causes of vision loss and common eye conditions.

T2D injectables: 1. Intensifying to first injectable therapy in uncomplicated type 2 diabetes

This education module focuses on a case study of an uncomplicated patient with type 2 diabetes, and the process of intensifying to first injectable therapy. Expert video commentary throughout the module helps step the participant through the decision cycle from the ADA/EASD consensus guidelines for T2D. This module also includes Australian recommendations for patients fasting during Ramadan.

T2D injectables: 2. Intensifying to first injectable therapy in patients with ASCVD risk

In this education module, the participant will work through a case study of a type 2 diabetes patient with ASCVD risk factors. The case study uses the decision cycle from the ADA/EASD consensus guidelines for T2D, and features expert video commentary. The module also discusses patient-related concerns leading to clinical inertia, including useful management decisions when faced with this issue.

T2D injectables: 3. Intensifying to first injectable therapy in patients with established ASCVD

This education module takes a case-study based look at the management of a type 2 diabetes patient with established ASCVD. Featuring expert video commentary, participants will use the decision cycle from the ADA/EASD consensus guidelines for T2D to work through a hypothetical case study. This module also discusses GP-related causes of clinical inertia, as well as additional patient factors such as obesity, low health literacy and diabetes distress.

Strong Steps program: Stepwise approach to identification and prevention of osteoporotic fracture

By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis or osteopenia, placing them at high risk of minimal trauma fracture. This program aims to support identification, evaluation and treatment of patients at high risk of osteoporotic fracture.

Pages